Showing results (1801-1810 of 1,967) with videos related to
Sort By:
Pageof 197
Epidemiology and Infection|March 23, 2022
Increased transmission of SARS-CoV-2 in Denmark during UEFA European championshipsMarc Bennedbæk, Mia Sarah Fischer Button, Lise Birk Nielsen, et al.Systematic Reviews|March 10, 2017
The effects of dietary and lifestyle interventions among pregnant women who are overweight or obese on longer-term maternal and early childhood outcomes: protocol for an individual participant data (IPD) meta-analysisJodie M Dodd, Rosalie M Grivell, Jennie Louise, et al.European Journal of Respiratory Medicine|February 23, 2024
Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent SubjectsNancy G Casanova, Sara M Camp, Manuel L Gonzalez-Garay, et al.Lancet (London, England)|April 3, 1998
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive DysfunctionJ T Moller, P Cluitmans, L S Rasmussen, et al.Endocrinology|February 28, 2002
Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitizationTerry P Combs, John A Wagner, Joel Berger, et al.Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 20, 2022
The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practiceHui-Lin Chin, Nour Gazzaz, Stephanie Huynh, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Selective PPARgamma modulators with improved pharmacological profilesKun Liu, Regina M Black, John J Acton, et al.JTO Clinical and Research Reports|September 30, 2021
Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese SubsetKazuto Nishio, Takashi Seto, Makoto Nishio, et al.Journal of Medicinal Chemistry|June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volumeJohn J Acton, Taro E Akiyama, Ching H Chang, et al.Pageof 197